Ratings IM Cannabis Corp. Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
0.626 ^USD	-1.40%		-11.84%	+75.35%

May. 08	Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024
May. 08	IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
The company's earnings releases usually do not meet expectations.

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
IM CANNABIS CORP.	+75.35%	7.35M	-	-
CURALEAF HOLDINGS, INC.	+26.68%	3.79B		C-
TRULIEVE CANNABIS CORP.	+130.51%	2.16B		C
GOODNESS GROWTH HOLDINGS, INC.	+179.37%	92.12M	-	-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality